FOXO3 and glioblastoma: We found a significant correlation between FOXO3 levels in GBM and the NSC signatures, where tumors with low FOXO3 activity (derepression of the FOXO3-repressed signature) also had low FOXO3 expression levels (p < 0.0001; Figure S6D).